Sales and Marketing

Showing 15 posts of 11524 posts found.

EU divided over patient information proposals

September 1, 2009 Sales and Marketing EFPIA, Europe, patient information

 Europe’s member states are at loggerheads over plans to relax current restrictions on pharma communicating with patients.The plans tabled by …

Basilea buoyed by sales increase

September 1, 2009 Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

Americans doubt benefits of health reform

August 27, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare

Most Americans are satisfied with their existing medical arrangements, according to a survey by Thomson Reuters.The results seem to be …

NICE criticised for rejection of kidney cancer drugs

August 27, 2009 Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

Venezuela restates threat to seize Pfizer plant

August 27, 2009 Manufacturing and Production, Sales and Marketing Pfizer, South America

The wrangling over Pfizer's manufacturing facility in Venezuela is continuing, with a senior official reiterating a threat to seize control …

Vasella adds voice to NHS criticism

August 27, 2009 Research and Development, Sales and Marketing NHS, healthcare

Novartis chief executive Daniel Vasella defended the industry's high cost oncology treatments, and said he would not want to be …

Warner Chilcott buys P&G pharma for $3.1 billion

August 25, 2009 Research and Development, Sales and Marketing MA, P&G, Warner Chilcott

Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …

Pfizer to develop online community to find new trials patients

August 24, 2009 Medical Communications, Research and Development, Sales and Marketing Pfizer, digi

Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials.Pfizer has …

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …

Avastin shows promise in advanced breast cancer

August 20, 2009 Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …

Novartis’ Extavia approved in US

August 19, 2009 Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …

US pharma accused of selling out to Obama

August 19, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare, industry

The US industry is accused of selling out to President Obama’s healthcare take-over, with its leaders seeking favourable treatment from …

Off-label rules for cancer need to be clarified

August 18, 2009 Research and Development, Sales and Marketing Cancer, NHS, off label

A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …
The Gateway to Local Adoption Series

Latest content